Atlas Trials

Antioxidants as Adjuvant Therapy to Standard Therapy in Patients With COVID-19

Clinical trial NCT04570254 · COMPLETED

Trial details

NCT number
NCT04570254
Sponsor
Unidad Temporal COVID-19 en Centro Citibanamex
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Pneumonia, ViralCovid19ARDSOxidative Stress
Start date
2020-08-19
Primary completion
2020-12-01
Enrollment
110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.